|
Volumn 73, Issue 2, 2000, Pages 125-126
|
Correlation of c-fos, p53, and PCNA expression with treatment outcome in osteosarcoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
METHOTREXATE;
PROTEIN P53;
ADULT;
CLINICAL ARTICLE;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LETTER;
MALE;
ONCOGENE C FOS;
OSTEOSARCOMA;
PATIENT SELECTION;
PREDICTION;
PRIORITY JOURNAL;
BONE NEOPLASMS;
HUMANS;
IMMUNOHISTOCHEMISTRY;
OSTEOSARCOMA;
PROLIFERATING CELL NUCLEAR ANTIGEN;
PROTO-ONCOGENE PROTEINS C-FOS;
TREATMENT OUTCOME;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 0034001744
PISSN: 00224790
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1096-9098(200002)73:2<125::AID-JSO14>3.0.CO;2-5 Document Type: Letter |
Times cited : (17)
|
References (6)
|